SCHEMBL29400266

SCHEMBL29400266

CCC(=O)c1ncc2[nH]cnc2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.44
▸ POLA1 P09884 1/20 0.39
▸ CDK2 P24941 2/20 0.38
▸ PAK1 Q13153 1/20 0.36
▸ MGMT P16455 2/20 0.36
▸ CCNT1 O60563 1/20 0.35
▸ CDK1 P06493 1/20 0.35
▸ CCNB1 P14635 1/20 0.35
▸ CDK7 P50613 1/20 0.35
▸ CDK9 P50750 1/20 0.35
▸ CCNH P51946 1/20 0.35
▸ BRAF P15056 1/20 0.34
▸ MAP3K7 O43318 1/20 0.34
▸ MAP3K6 O95382 1/20 0.34
▸ MAP3K5 Q99683 1/20 0.34
▸ TP53 P04637 1/20 0.32
▸ CTSA P10619 1/20 0.32
▸ XDH P47989 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7771676 0.81 ALDH1A1 (0.50) KDM4EALDH1A1RXFP1POLA1CDK2
SCHEMBL14125940 0.80 KDM4E (0.46) KDM4EALDH1A1RXFP1BRAFTP53
SCHEMBL788098 0.80 ALDH1A1 (0.52) KDM4EALDH1A1RXFP1POLA1CDK2
SCHEMBL30556758 0.78 ALDH1A1 (0.50) KDM4EALDH1A1RXFP1POLA1CDK2
SCHEMBL29599053 0.78 RXFP1 (0.51) KDM4EALDH1A1RXFP1POLA1CDK2
SCHEMBL1721311 0.78 ALDH1A1 (0.55) KDM4EALDH1A1RXFP1POLA1CDK2
SCHEMBL28011628 0.78 CDK2 (0.46) KDM4EALDH1A1RXFP1POLA1CDK2
SCHEMBL30119558 0.77 ALDH1A1 (0.46) KDM4EALDH1A1RXFP1POLA1CDK2
SCHEMBL28339944 0.76 ALDH1A1 (0.45) KDM4EALDH1A1RXFP1POLA1CDK2
SCHEMBL28190667 0.75 ALDH1A1 (0.47) KDM4EALDH1A1RXFP1POLA1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114096250-A Novel therapy for erythropoietic protoporphyrinopathy (EPP) and X-linked protoporphyrinopathy (XLP) 匹兹堡大学联邦高等教育系统 2022-02-25 — — CN disclosed
Send feedback